Teleflex Incorporated $TFX Shares Purchased by Wealth Enhancement Advisory Services LLC

Key Points

• Wealth Enhancement Advisory Services LLC increased its stake in Teleflex Incorporated by 759.8% during Q2, now holding 27,135 shares worth approximately $3.25 million.
• Teleflex reported quarterly earnings of $3.73 per share, surpassing analysts' estimates of $3.36, with a revenue of $780.90 million, reflecting a 4.2% increase year-over-year.
• Teleflex announced a quarterly dividend of $0.34 per share, with an annualized dividend of $1.36 and a dividend yield of 1.1%.

Wealth Enhancement Advisory Services LLC boosted its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 759.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,135 shares of the medical technology company's stock after buying an additional 23,979 shares during the quarter. Wealth Enhancement Advisory Services LLC owned 0.06% of Teleflex worth $3,253,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in TFX. Dimensional Fund Advisors LP lifted its holdings in Teleflex by 69.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 867,864 shares of the medical technology company's stock worth $119,927,000 after buying an additional 355,720 shares in the last quarter. Diamond Hill Capital Management Inc. lifted its holdings in Teleflex by 122.8% in the 1st quarter. Diamond Hill Capital Management Inc. now owns 584,586 shares of the medical technology company's stock worth $80,784,000 after buying an additional 322,222 shares in the last quarter. Invenomic Capital Management LP lifted its holdings in Teleflex by 1,400.1% in the 1st quarter. Invenomic Capital Management LP now owns 344,732 shares of the medical technology company's stock worth $47,639,000 after buying an additional 321,751 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in Teleflex by 229.9% in the 1st quarter. Principal Financial Group Inc. now owns 230,522 shares of the medical technology company's stock worth $31,856,000 after buying an additional 160,646 shares in the last quarter. Finally, Millennium Management LLC lifted its holdings in Teleflex by 57.8% in the 1st quarter. Millennium Management LLC now owns 394,633 shares of the medical technology company's stock worth $54,534,000 after buying an additional 144,531 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.

Insider Buying and Selling at Teleflex

In other Teleflex news, Director Stuart A. Randle acquired 1,000 shares of the stock in a transaction that occurred on Tuesday, August 5th. The stock was acquired at an average price of $115.86 per share, with a total value of $115,860.00. Following the transaction, the director directly owned 7,547 shares in the company, valued at approximately $874,395.42. This represents a 15.27% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Andrew A. Krakauer bought 1,000 shares of the firm's stock in a transaction on Tuesday, August 5th. The stock was purchased at an average price of $115.25 per share, with a total value of $115,250.00. Following the transaction, the director owned 7,192 shares in the company, valued at $828,878. The trade was a 16.15% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 5,500 shares of company stock worth $633,590. 1.40% of the stock is owned by company insiders.

Teleflex Price Performance

Shares of NYSE:TFX opened at $120.13 on Friday. The company has a quick ratio of 1.44, a current ratio of 2.41 and a debt-to-equity ratio of 0.42. Teleflex Incorporated has a fifty-two week low of $108.90 and a fifty-two week high of $249.90. The firm has a 50-day simple moving average of $122.42 and a 200 day simple moving average of $125.25. The company has a market cap of $5.31 billion, a PE ratio of 28.26, a P/E/G ratio of 1.63 and a beta of 1.08.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, beating analysts' consensus estimates of $3.36 by $0.37. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The business had revenue of $780.90 million during the quarter, compared to the consensus estimate of $771.53 million. During the same quarter in the prior year, the firm earned $3.42 EPS. The company's revenue for the quarter was up 4.2% compared to the same quarter last year. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. On average, sell-side analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 15th. Investors of record on Friday, August 15th were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend was Friday, August 15th. Teleflex's dividend payout ratio is currently 32.00%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on TFX shares. Wells Fargo & Company dropped their target price on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a research report on Friday, August 1st. Mizuho boosted their target price on shares of Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a research report on Friday, August 1st. Wall Street Zen downgraded shares of Teleflex from a "strong-buy" rating to a "buy" rating in a research report on Monday, September 15th. Finally, Royal Bank Of Canada boosted their target price on shares of Teleflex from $130.00 to $135.00 and gave the stock a "sector perform" rating in a research report on Friday, August 1st. One analyst has rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $141.57.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.